9 Things to Know About Cannabis for Menopause Symptoms
The number of women quietly asking about cannabis — usually in hushed tones, as if it is still 1987 — is striking. There is no judgment here, only a wish that the research were better so there were clearer answers to give. Until it is, knowing exactly where the evidence stands and where it does not is the most useful thing anyone can offer.
Learn more about Rose →Most of what is known comes from surveys, not clinical trials
The bulk of existing evidence on cannabis use in menopause comes from self-reported surveys, including a widely cited 2020 study in Menopause journal in which nearly 27% of respondents reported using cannabis for symptom relief. Surveys capture prevalence and perceived benefit, but they cannot establish cause and effect, control for placebo response, or identify who is most likely to be helped or harmed. This gap is not a reason to dismiss the topic — it is a reason to read all other claims in this article with that context firmly in mind.
The endocannabinoid system is genuinely relevant to menopause biology
The body has its own endocannabinoid system — a network of receptors (CB1 and CB2) that helps regulate mood, sleep, pain perception, body temperature, and stress response, all of which are disrupted during the menopause transition. Estrogen influences the density and sensitivity of these receptors, which means declining estrogen during perimenopause may alter how the system functions. This biological plausibility is why researchers consider the topic worth studying — it is not just wishful thinking — but plausibility alone is not the same as proven efficacy.
Sleep is the symptom women most commonly report treating with cannabis
Across multiple surveys, insomnia and poor sleep quality rank as the top reasons menopausal women use cannabis, and some small studies in general adult populations suggest THC can reduce the time it takes to fall asleep. However, regular THC use has been shown to suppress REM sleep, which is the restorative dream stage, and rebound insomnia when stopping is well documented. Women already struggling with sleep architecture changes driven by hormonal shifts may find the short-term gain creates a longer-term problem.
There is no clinical trial evidence that cannabis reduces hot flashes
Hot flash relief is one of the most commonly reported reasons women try cannabis, and the endocannabinoid system does interact with the hypothalamic thermoregulatory pathways that go haywire during menopause. However, as of the current evidence base, no randomized controlled trial has tested cannabis specifically for vasomotor symptoms in menopausal women. What exists is survey data showing women believe it helps — which is meaningful information about perception, but not confirmation of a physiological effect on core body temperature fluctuation.
CBD and THC are not the same thing and should not be treated as interchangeable
THC (tetrahydrocannabinol) is the psychoactive compound that produces a high and carries most of the risks around dependency, cognitive effects, and anxiety in susceptible people. CBD (cannabidiol) is non-intoxicating and has a more favorable safety profile in the research to date, though robust menopause-specific evidence for CBD is also largely absent. When women report using cannabis for menopause, the specific compound, dose, delivery method, and frequency matter enormously — pooling all cannabis use into one category makes interpreting outcomes nearly impossible.
Anxiety and mood symptoms are commonly cited as targets, with mixed signals from the evidence
Low-dose THC and some CBD formulations have shown anxiolytic (anxiety-reducing) effects in general population studies, and menopausal women frequently report using cannabis to manage mood instability, irritability, and anxiety. The complication is that higher doses of THC are associated with increased anxiety and paranoia in a significant subset of users, and perimenopausal women may already have a sensitized stress-response system. The dose-response relationship for anxiety is non-linear, meaning more is not better and individual response is highly variable.
Genitourinary symptoms and sexual pain are an area of active interest but thin evidence
Topical CBD and THC products marketed for vulvovaginal dryness and pain during sex have grown substantially as a product category, and anecdotal reports of benefit are common. A small number of preliminary studies suggest cannabinoids may have local anti-inflammatory and muscle-relaxant effects relevant to pelvic pain. However, no peer-reviewed clinical trials have specifically tested these products for genitourinary syndrome of menopause, and vaginal tissue absorbs compounds differently than skin — the pharmacology of topical genital application is not well characterized.
There are real risks that deserve honest attention, particularly around cognition and dependency
Regular cannabis use — particularly high-THC products — is associated in the broader literature with impacts on verbal memory, processing speed, and executive function, which matters because cognitive changes are already a common and distressing part of the menopause transition for many women. Cannabis use disorder is a recognized clinical condition affecting roughly 9% of people who use cannabis, with higher rates among daily users. Women considering cannabis for symptom management deserve to weigh these risks with the same seriousness they would apply to any other intervention.
Cannabis is not a substitute for evidence-based menopause treatments, but the conversation with a doctor is worth having
For vasomotor symptoms, mood disruption, and sleep, hormone therapy and several non-hormonal options have strong clinical trial evidence behind them — cannabis currently does not reach that bar for any menopause-specific indication. That said, many women are already using it, and a non-judgmental, informed conversation with a healthcare provider is far more useful than silence on both sides. Clinicians who specialize in menopause are increasingly familiar with these questions, and honesty about use matters for safety, particularly around drug interactions and cardiovascular considerations.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.